Intermediate dose melphalan, Bortezomib, Thalidomide, Dexametasone (MVTD) conditioning therapy and ASCT in relapsed multiple myeloma patients: A single center experience

被引:1
|
作者
Scalzulli, Polito Rosario [1 ]
Valvano, Maria Rosa [1 ]
Bodenizza, Carlo C. [1 ]
Carella, Angelo Michele [1 ]
Dell'Olio, Matteo M. [1 ]
Falcone, Antonietta A. P. [1 ]
Greco, Michele Mario [1 ]
La Sala, Antonio A. [1 ]
Mantuano, Francesco F. S. [1 ]
Melillo, Lorella L. [1 ]
Merla, Emanuela E. [1 ]
Nobile, Michele M. [1 ]
Sanpaolo, G. Sanpaolo [1 ]
Cascavilla, Nicola N. [1 ]
机构
[1] Casa Sollieva Sofferenza Hosp, IRCCS, San Giovanni Rotondo FG, Foggia, Italy
关键词
D O I
10.1182/blood.V110.11.5117.5117
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
5117
引用
收藏
页码:361B / 361B
页数:1
相关论文
共 50 条
  • [1] Autologous stem cell transplantation (ASCT) after conditioning therapy with intermediate dose melphalan, bortezomib,thalidomide, dexamethasone (MVTD) in relapsed multiple myeloma (MM) patients
    Scalzulli, P. R.
    Bodenizza, C.
    Carella, A. M.
    Dell'Olio, M.
    Falcone, A. P.
    Greco, M. M.
    La Sala, A.
    Mantuano, S.
    Melillo, L.
    Merla, E.
    Nobile, M.
    Sanpaolo, G.
    Valvano, M. R.
    Cascavilla, N.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 212 - 212
  • [2] Autologus stem cell transplantation (ASCT) conditioning therapy intermediate dose Melphalan, Bortezomib, Thalidomide, Dexamethasone (MVRO) in relapsed multiple myeloma (MM)
    Scalzulli, P. R.
    Bodenizza, C. A.
    Carella, A. M.
    Dell'Olio, M.
    Falcone, A. P.
    Greco, M. M.
    La Sala, A.
    Mantuano, S.
    Melillo, L.
    Merla, E.
    Nobile, M.
    Sanpaolo, G.
    Musto, P.
    Valvano, M. R.
    Cascavilla, N.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 437 - 437
  • [3] Bortezomib, melphalan, prednisone, and thalidomide for relapsed multiple myeloma
    Palumbo, Antonio
    Ambrosini, Maria Teresa
    Benevolo, Giulia
    Pregno, Patrizia
    Pescosta, Norbert
    Callea, Vincenzo
    Cangialosi, Clotilde
    Caravita, Tommaso
    Morabito, Fortunato
    Musto, Pellegrino
    Bringhen, Sara
    Falco, Patrizia
    Avonto, Ilaria
    Cavallo, Federica
    Boccadoro, Mario
    [J]. BLOOD, 2007, 109 (07) : 2767 - 2772
  • [4] Bortezomib in combination with low-dose oral melphalan, dexamethasone and thalidomide for relapsed elderly patients with multiple myeloma
    Azarm, Taleb
    Akbari, Mojtaba
    Azarm, Arezo
    Mohager, Hamid
    [J]. JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2012, 17 (01): : 8 - 14
  • [5] VAMP/ThaCyDex: Velcade® (Bortezomib), Adriamycin, Melphalan and Prednisone Alternating with Thalidomide, Cyclophosphamide and Dexametasone as a Salvage Regimen in Relapsed Multiple Myeloma Patients.
    Colado, Enrique
    Mateos, Maria-Victoria
    Moreno, Maria-Jose
    Dearriba, Felipe
    de la Rubia, Javier
    Lahuerta, Juan Jose
    Iniesta, Pastora
    Viguria, Maria Cruz
    Gonzalez, Ana Pilar
    Garcia-Sanz, Ramon
    Olazabal, Juan
    Miguel, Jesus F. San
    [J]. BLOOD, 2008, 112 (11) : 1265 - 1266
  • [6] Bortezomib in relapsed and refractory multiple myeloma patients.: Experience of a single center
    Calabrese, E.
    Gallucci, C.
    Federico, V
    Mohamad, A.
    Foa, R.
    Petrucci, M. T.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 151 - 151
  • [7] CONDITIONING CHEMOTHERAPY WITH BORTEZOMIB AND MELPHALAN 200 IN PATIENTS WITH MULTIPLE MYELOMA SUBJECTED TO AUTO-TPH. A SINGLE CENTER EXPERIENCE
    Llorente Dunia, De Miguel
    Sanz Dolores, Morales
    Maqueda Cristina, Fernandez
    Lopez Nuria, Golbano
    Morfa Miguel, Diaz
    Perez Dolores, Subira
    Ramo Alejandro, Vazquez
    Martin Sonia, Herrero
    Albiz Blanca, Pinedo
    Juanis Jaime, Arbeteta
    [J]. HAEMATOLOGICA, 2016, 101 : 117 - 118
  • [8] Low dose intravenous melphalan and bortezomib for relapsed multiple myeloma
    Popat, R
    Oakervee, HE
    Foot, N
    Agrawal, S
    Odeh, L
    Craddock, C
    Williams, C
    Basu, S
    Williams, C
    Basu, S
    Cavenagh, JD
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 : 98 - 98
  • [9] BORTEZOMIB, LOW DOSE INTRAVENOUS MELPHALAN AND DEXAMETHASONE FOR PATIENTS WITH RELAPSED MULTIPLE MYELOMA
    Popat, R.
    Oakervee, H.
    Williams, C.
    Cook, M.
    Craddock, C.
    Basu, S.
    Singer, C.
    Odeh, L.
    Foot, N.
    Joel, S.
    Hallam, S.
    Harding, S.
    Mead, G.
    Cavenagh, J.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 365 - 366
  • [10] Bortezomib, low dose iv melphalan and dexamethasone for patients with relapsed multiple myeloma
    Popat, R.
    Williams, C.
    Cook, M.
    Craddock, C.
    Basu, S.
    Singer, C.
    Odeh, L.
    Foot, N.
    Joel, S.
    Hallam, S.
    Oakervee, H.
    Cavenagh, J.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 : 120 - 120